Overview

A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.

Status:
Completed
Trial end date:
2009-03-06
Target enrollment:
Participant gender:
Summary
This study is intended to assess safety and tolerability of ASP1941 compared to placebo in adult subjects with type 2 diabetes mellitus
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin